Neumora Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:NMRA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Nov 23	BuyUS$412,140	Arch Venture Partners, L.P.	Company	35,010	US$11.98
10 Nov 23	BuyUS$1,543,563	Arch Venture Partners, L.P.	Company	140,605	US$11.79
07 Nov 23	BuyUS$1,099,945	Arch Venture Partners, L.P.	Company	95,694	US$11.55
29 Sep 23	BuyUS$1,046,848	Arch Venture Partners, L.P.	Company	76,511	US$13.98
27 Sep 23	BuyUS$700,464	Arch Venture Partners, L.P.	Company	58,504	US$12.31
25 Sep 23	BuyUS$1,127,064	Arch Venture Partners, L.P.	Company	100,740	US$11.65
19 Sep 23	BuyUS$189,371	Henry Gosebruch	Individual	15,000	US$12.62
19 Sep 23	BuyUS$29,999,985	Amgen Inc.	Company	1,764,705	US$17.00
19 Sep 23	BuyUS$25,500,000	Arch Venture Partners, L.P.	Company	1,500,000	US$17.00

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: NMRA only recently listed within the past 12 months

Top 25 shareholders own 82.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
22.2%	Amgen Inc.	35,368,653	US$331.8m	0%	no data
20%	Arch Venture Partners, L.P.	31,932,138	US$299.5m	0%	25.2%
4.93%	Biomatics Capital Partners	7,861,859	US$73.7m	0%	100.0%
4.79%	Paul Berns	7,646,916	US$71.7m	0%	no data
4.79%	SoftBank Group Corp., Investment Arm	7,646,916	US$71.7m	0%	2.35%
3.53%	Impresa Management LLC	5,624,353	US$52.8m	0%	23.89%
2.8%	Mic Capital Management Uk Llp	4,460,700	US$41.8m	0%	8.42%
2.72%	T. Rowe Price Group, Inc.	4,336,928	US$40.7m	509,000%	no data
2.13%	ICONIQ Capital, LLC	3,398,628	US$31.9m	0%	0.71%
2.07%	Wellcome Trust, Investment Division	3,309,123	US$31.0m	0%	0.35%
1.83%	Artal Group S.A.	2,924,052	US$27.4m	14.6%	0.7%
1.3%	EcoR1 Capital, LLC	2,071,450	US$19.4m	0%	0.61%
1.16%	FMR LLC	1,858,012	US$17.4m	148%	no data
1.16%	Johnson & Johnson Innovation - JJDC, Inc.	1,849,445	US$17.3m	0%	5.23%
1.14%	Citadel Advisors LLC	1,823,983	US$17.1m	-1.05%	0.02%
1.13%	Avidity Partners Management, L.P.	1,800,000	US$16.9m	-9.58%	0.72%
0.94%	OrbiMed Advisors LLC	1,500,000	US$14.1m	0%	0.21%
0.63%	Deep Track Capital, LP	1,000,000	US$9.4m	0%	0.28%
0.62%	BlackRock, Inc.	985,571	US$9.2m	-5.6%	no data
0.57%	Soros Capital Management LLC	904,016	US$8.5m	0%	2.48%
0.43%	Balyasny Asset Management L.P.	688,169	US$6.5m	0%	0.02%
0.41%	Rock Springs Capital Management LP	646,118	US$6.1m	0%	0.18%
0.4%	Baker Bros. Advisors LP	633,851	US$5.9m	0%	0.09%
0.36%	John Dunlop	573,517	US$5.4m	0%	no data
0.33%	Henry Gosebruch	524,793	US$4.9m	0%	no data